The Economics of Everyday Things

23. Cadavers - Part 2

March 19, 2026

Key Takeaways Copied to clipboard!

  • The trade of human body parts for research operates with minimal to no federal regulation, unlike live organ and tissue donation. 
  • A single cadaver can generate between $5,000 and $10,000 when dissected and sold to various buyers, including medical device manufacturers who use the parts for surgical training workshops. 
  • Philip Guyette, a former body broker with no formal training, earned substantial income by selling body parts and recycling metals from cremated remains, highlighting the commodification of the human body. 

Segments

Lack of Regulation in Body Brokering
Copied to clipboard!
(00:00:47)
  • Key Takeaway: Chopping up and selling human bodies requires no funeral director’s license or medical degree, indicating a severe lack of regulation.
  • Summary: Many jobs require credentials, but dissecting human bodies for research requires no specific licensing. The interviewee could disassemble a body within 15 minutes without any medical or funeral director certification. This highlights the minimal legal oversight in the trade of human remains for research purposes.
Cadaver Sourcing and University Needs
Copied to clipboard!
(00:03:05)
  • Key Takeaway: Medical schools often have strict geographic limitations when sourcing cadavers, forcing suppliers to network widely for excess bodies.
  • Summary: The initial job involved sourcing 80 cadavers annually for a university with 250 anatomy students. Many schools only accepted donations from within a 50-mile radius of their institution. This scarcity and restriction drove the need to scrounge for excess cadavers from other medical schools.
Body Part Market Value
Copied to clipboard!
(00:05:02)
  • Key Takeaway: Individual body parts command high prices, with a whole cadaver fetching $5,000 to $10,000 when segmented for research.
  • Summary: Researchers and medical device companies pay significant amounts for specific parts, such as $500 for a head or $350,000 for a foot, though the latter figure seems highly anomalous based on context. Limbs and extremities alone yield about $5,000, with additional revenue generated from organ and research tissue sales.
Donor Acquisition Methods
Copied to clipboard!
(00:06:37)
  • Key Takeaway: Body brokers target elderly donors through end-of-life facilities and offer free cremation as an incentive to low-income families.
  • Summary: The interviewee ran ads in obituaries and built relationships with hospice nurses to find donors, 90% of whom were over 65. Offering free cremation, which averages $2,000, is an attractive incentive for families facing high end-of-life costs. Consent forms are often vague, misleading families about the extent of body dissection.
Dissection Practices and Buyers
Copied to clipboard!
(00:08:22)
  • Key Takeaway: Dissection for research often uses basic tools, and the largest buyers are medical equipment manufacturers hosting training workshops.
  • Summary: The interviewee, lacking formal training, used Home Depot tools for dissection because sterility was not required as parts were frozen. Major buyers include companies like 3M and Johnson & Johnson, who purchase parts like 250 heads for rhinoplasty lectures at conventions. Other buyers include cadaver dog training courses needing tissue in various stages of decomposition.
Ancillary Income Streams
Copied to clipboard!
(00:13:36)
  • Key Takeaway: Significant secondary income was generated by recycling metals, such as cobalt, titanium, and dental gold, left over after cremation.
  • Summary: The interviewee made between $350,000 and $500,000 annually recycling HIPAA implants containing cobalt and titanium. An additional $25,000 to $50,000 monthly came from dental gold recovered from remains. This demonstrates how the entire human body is treated as a commodity with multiple revenue streams.
Broker Controversies and Legal Consequences
Copied to clipboard!
(00:14:14)
  • Key Takeaway: The industry is plagued by controversies, including selling tissue for live transplants using altered health records, leading to felony convictions.
  • Summary: Recent controversies include a Harvard director selling parts for doll making and a $58 million settlement against a Phoenix firm for lying to families. Guyette himself was convicted of wire fraud for selling diseased tissue for live transplants after altering medical records, resulting in an eight-year prison sentence. Despite his conviction, he notes others believe they can operate the business more successfully.